John M. Bedtelyon

Array ( [id] => 6054500 [patent_doc_number] => 20110110860 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-12 [patent_title] => 'MODULATION OF LDL RECEPTOR GENE EXPRESSION WITH DOUBLE-STRANDED RNAS TARGETING THE LDL RECEPTOR GENE PROMOTER' [patent_app_type] => utility [patent_app_number] => 12/938253 [patent_app_country] => US [patent_app_date] => 2010-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 43 [patent_figures_cnt] => 43 [patent_no_of_words] => 23429 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0110/20110110860.pdf [firstpage_image] =>[orig_patent_app_number] => 12938253 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8305908 [patent_doc_number] => 08227443 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-07-24 [patent_title] => 'Silencing of CSN5 gene expression using interfering RNA' [patent_app_type] => utility [patent_app_number] => 12/903558 [patent_app_country] => US [patent_app_date] => 2010-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 30 [patent_no_of_words] => 45375 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12903558 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7696046 [patent_doc_number] => 20110230544 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-22 [patent_title] => 'MODULATION OF C-REACTIVE PROTEIN EXPRESSION' [patent_app_type] => utility [patent_app_number] => 12/902051 [patent_app_country] => US [patent_app_date] => 2010-10-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 49452 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0230/20110230544.pdf [firstpage_image] =>[orig_patent_app_number] => 12902051 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8708650 [patent_doc_number] => 20130065939 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-03-14 [patent_title] => 'COMPOSITIONS AND METHODS FOR SILENCING GENES EXPRESSED IN CANCER' [patent_app_type] => utility [patent_app_number] => 13/497789 [patent_app_country] => US [patent_app_date] => 2010-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 70 [patent_figures_cnt] => 70 [patent_no_of_words] => 103039 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13497789 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10155986 [patent_doc_number] => 09187746 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-11-17 [patent_title] => 'Dual targeting siRNA agents' [patent_app_type] => utility [patent_app_number] => 13/497226 [patent_app_country] => US [patent_app_date] => 2010-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 50182 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 98 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13497226 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6096081 [patent_doc_number] => 20110003307 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-06 [patent_title] => 'METHODS FOR PRODUCING INTERFERING RNA MOLECULES IN MAMMALIAN CELLS AND THERAPEUTIC USES FOR SUCH MOLECULES' [patent_app_type] => utility [patent_app_number] => 12/881509 [patent_app_country] => US [patent_app_date] => 2010-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 7697 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0003/20110003307.pdf [firstpage_image] =>[orig_patent_app_number] => 12881509 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9662313 [patent_doc_number] => 08809289 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-08-19 [patent_title] => 'Double-stranded nucleic acid molecule, cancer cell proliferation inhibitor and pharmaceutical agent suitable for prevention or treatment of cancer' [patent_app_type] => utility [patent_app_number] => 12/879305 [patent_app_country] => US [patent_app_date] => 2010-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 29 [patent_no_of_words] => 10289 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12879305 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5929954 [patent_doc_number] => 20110039913 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-17 [patent_title] => 'ANTISENSE MODULATION OF HYDROXYSTEROID 11-BETA DEHYDROGENASE 1 EXPRESSION' [patent_app_type] => utility [patent_app_number] => 12/860181 [patent_app_country] => US [patent_app_date] => 2010-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29972 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0039/20110039913.pdf [firstpage_image] =>[orig_patent_app_number] => 12860181 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6388959 [patent_doc_number] => 20100317718 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-16 [patent_title] => 'MODULATION OF HIF1 BETA EXPRESSION' [patent_app_type] => utility [patent_app_number] => 12/846746 [patent_app_country] => US [patent_app_date] => 2010-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30367 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0317/20100317718.pdf [firstpage_image] =>[orig_patent_app_number] => 12846746 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6622742 [patent_doc_number] => 20100311082 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-09 [patent_title] => 'Stable Cell Lines and Methods for Evaluating Gastrointestinal Absorption of Chemicals' [patent_app_type] => utility [patent_app_number] => 12/843706 [patent_app_country] => US [patent_app_date] => 2010-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 25992 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0311/20100311082.pdf [firstpage_image] =>[orig_patent_app_number] => 12843706 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6383306 [patent_doc_number] => 20100317049 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-16 [patent_title] => 'Stable Cell Lines and Methods for Evaluating Gastrointestinal Absorption of Chemicals' [patent_app_type] => utility [patent_app_number] => 12/843536 [patent_app_country] => US [patent_app_date] => 2010-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 25990 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0317/20100317049.pdf [firstpage_image] =>[orig_patent_app_number] => 12843536 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8359726 [patent_doc_number] => 20120214862 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-23 [patent_title] => 'MODULATION OF FACTOR 7 EXPRESSION' [patent_app_type] => utility [patent_app_number] => 13/384327 [patent_app_country] => US [patent_app_date] => 2010-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 36797 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13384327 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8187560 [patent_doc_number] => 20120116360 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-10 [patent_title] => 'TREATMENT OF NEUROLOGICAL DISORDERS' [patent_app_type] => utility [patent_app_number] => 13/383560 [patent_app_country] => US [patent_app_date] => 2010-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 16208 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0116/20120116360.pdf [firstpage_image] =>[orig_patent_app_number] => 13383560 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10831345 [patent_doc_number] => 08859515 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-10-14 [patent_title] => 'Treatment of tumor necrosis factor receptor 2 (TNFR2) related diseases by inhibition of natural antisense transcript to TNFR2' [patent_app_type] => utility [patent_app_number] => 13/379728 [patent_app_country] => US [patent_app_date] => 2010-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 25535 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 104 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13379728 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10077562 [patent_doc_number] => 09115404 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-08-25 [patent_title] => 'Polynucleotides for medical use' [patent_app_type] => utility [patent_app_number] => 13/379084 [patent_app_country] => US [patent_app_date] => 2010-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 39 [patent_figures_cnt] => 52 [patent_no_of_words] => 24003 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13379084 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8313711 [patent_doc_number] => 20120190728 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-07-26 [patent_title] => 'COMPOSITIONS AND METHODS FOR MODULATION OF SMN2 SPLICING IN A SUBJECT' [patent_app_type] => utility [patent_app_number] => 13/380021 [patent_app_country] => US [patent_app_date] => 2010-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 24574 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13380021 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8265974 [patent_doc_number] => 20120165401 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-06-28 [patent_title] => 'APTAMER FOR CHYMASE, AND USE THEREOF' [patent_app_type] => utility [patent_app_number] => 13/377201 [patent_app_country] => US [patent_app_date] => 2010-06-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 24021 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13377201 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8976084 [patent_doc_number] => 20130209514 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-08-15 [patent_title] => 'APTAMER-TARGETED COSTIMULATORY LIGAND APTAMER' [patent_app_type] => utility [patent_app_number] => 13/376873 [patent_app_country] => US [patent_app_date] => 2010-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 24612 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13376873 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8555197 [patent_doc_number] => 08329670 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-12-11 [patent_title] => 'System for delivering nucleic acids for suppressing target gene expression by utilizing endogenous chylomicron' [patent_app_type] => utility [patent_app_number] => 12/787552 [patent_app_country] => US [patent_app_date] => 2010-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 12284 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12787552 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8265964 [patent_doc_number] => 20120165391 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-06-28 [patent_title] => 'USE OF INHIBITORS OF ZDHHC2 ACTIVITY FOR MODULATION OF ADIPOGENESIS' [patent_app_type] => utility [patent_app_number] => 13/321013 [patent_app_country] => US [patent_app_date] => 2010-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6299 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13321013 [rel_patent_id] =>[rel_patent_doc_number] =>)